Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SweMed (SweMed Lab International AB) is a Swedish medical technology company specializing in the development and manufacture of high-quality medical devices for assisted reproduction (IVF). The company is best known for its range of oocyte aspiration needles, embryo transfer catheters, and other specialized tools used in fertility clinics worldwide. Founded in 1986, SweMed established a strong reputation for precision and innovation in the Assisted Reproductive Technology (ART) field before being acquired by Vitrolife in 2011. Today, its products are integrated into the Vitrolife portfolio, continuing to support clinicians in optimizing pregnancy outcomes through advanced medical engineering. The acquisition allowed for the global expansion of SweMed's specialized product lines under a leading reproductive health brand.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Swemed.